Advertisement

Spinal Tech

Advertisement

Here are five updates to know on medtech company Stryker that Becker's reported on during the fourth quarter:

Onward's Arc-Ex spinal cord stimulator earned the FDA's de novo classification and U.S. market authorization, according to a Dec. 19 news release. 

Advertisement